The Chemours Company announced its strategic decision to cease sales of Freon 404A (R-404A) and Freon 507 (R-507) in the United States. Chemours-the inventors of Freon and Opteon(TM) refrigerant portfolios -will discontinue U.S. sales of these select Freon products as of May 2, 2024, in support of regulatory phasedown requirements.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours sees Q2 revenue up 15% q/q, implying $1.61B, consensus $1.55B
- Chemours reports Q1 EPS 34c, consensus 18c
- Chemours Company Announces Executive Jonathan Lock’s Departure
- Chemours upgraded to Outperform from Market Perform at BMO Capital
- The Chemours Company Class Action: Levi & Korsinsky LLP Reminds The Chemours Company Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 20, 2024 – CC